Indole Diterpene Derivatives from the Aspergillus flavus GZWMJZ-288, an Endophytic Fungus from Garcinia multiflora

Dongyang Wang,Xiaohong Zhuang,Ying Yin,Dan Wu,Wenwen He,Weiming Zhu,Yanchao Xu,Mingxing Zuo,Liping Wang

DOI: https://doi.org/10.3390/molecules28237931

IF: 4.6

2023-12-04

Molecules

Abstract:A new indole diterpene, 26-dihydroxyaflavininyl acetate (1), along with five known analogs (2–6) were isolated from the liquid fermentation of Aspergillus flavus GZWMJZ-288, an endophyte from Garcinia multiflora. The structures of these compounds were identified through NMR, MS, chemical reaction, and X-ray diffraction experiments. Enzyme inhibition activity screening found that compounds 1, 4, and 6 have a good binding affinity with NPC1L1, among which compound 6 exhibited a stronger binding ability than ezetimibe at a concentration of 10 μM. Moreover, compound 5 showed inhibitory activity against α-glucosidase with an IC50 value of 29.22 ± 0.83 μM, which is 13 times stronger than that of acarbose. The results suggest that these aflavinine analogs may serve as lead compounds for the development of drugs targeting NPC1L1 and α-glucosidase. The binding modes of the bioactive compounds with NPC1L1 and α-glucosidase were also performed through in silico docking studies.

chemistry, multidisciplinary,biochemistry & molecular biology

What problem does this paper attempt to address?

The paper mainly investigates a new indole diterpenoid compound (26-dihydroxyaflavininyl acetate, 1) isolated from the endophytic fungus Aspergillus flavus GZWMJZ-288, as well as five known analogues (2-6). These compounds are structurally similar to aflavinine. Their structures were determined through nuclear magnetic resonance (NMR), mass spectrometry (MS), chemical reactions, and X-ray diffraction experiments. It was found that compounds 1, 4, and 6 exhibited good binding ability to NPC1L1, a membrane protein related to cholesterol absorption, with compound 6 showing a binding ability surpassing the existing inhibitor ezetimibe. In addition, compound 5 showed inhibitory activity against α-glucosidase, with an IC50 value of 29.22±0.83 μM, approximately 13 times stronger than acarbose. These results suggest that aflavinine-like compounds could serve as potential drug precursors for the development of NPC1L1 and α-glucosidase inhibitors. Further studies on the binding modes of these bioactive compounds with target enzymes were conducted through computer-aided molecular docking. In conclusion, this paper aims to explore the possibilities of these compounds as enzyme inhibitors and provides new clues for the development of novel cholesterol-lowering drugs.